BACKGROUND: Vascular endothelial growth factor (VEGF) is a potent proangiogenic cytokine, and it also increases vascular permeability. It is well known that VEGF levels are increased in the airway of asthmatic patients. Hypoxia-inducible factor (HIF) induces a rapid and strong increase in VEGF expression. OBJECTIVES: To evaluate the relationship between VEGF level and clinical characteristics and to determine whether VEGF expression is associated with HIF expression in asthmatic patients. METHODS: Bronchoscopy was performed on 30 asthmatic patients and 14 control subjects. The concentration of VEGF in the bronchoalveolar lavage fluid (BALF) was examined using enzyme-linked immunosorbent assay. We measured VEGF, HIF-1alpha, and HIF-2alpha expression on biopsy specimens by means of immunoreactivity. RESULTS: The VEGF level in the BALF was significantly higher in asthmatic patients than in controls. The VEGF level correlated with eosinophil counts in the BALF in asthmatic subjects (r = 0.501; P < .01). However, the VEGF level did not correlate with percentage of forced expiratory volume in 1 second and airway hyperresponsiveness. Asthmatic patients exhibited higher VEGF, HIF-1alpha, and HIF-2alpha immunoreactivity in the submucosa than did controls. Furthermore, VEGF expression correlated significantly with HIF-1alpha (r = 0.614; P = .02) and HIF-2alpha (r = 0.881; P = .001) expression. CONCLUSION: These findings suggest that VEGF may play an important role in inflammation and that VEGF level is related to HIF in bronchial asthma.
BACKGROUND:Vascular endothelial growth factor (VEGF) is a potent proangiogenic cytokine, and it also increases vascular permeability. It is well known that VEGF levels are increased in the airway of asthmatic patients. Hypoxia-inducible factor (HIF) induces a rapid and strong increase in VEGF expression. OBJECTIVES: To evaluate the relationship between VEGF level and clinical characteristics and to determine whether VEGF expression is associated with HIF expression in asthmatic patients. METHODS: Bronchoscopy was performed on 30 asthmatic patients and 14 control subjects. The concentration of VEGF in the bronchoalveolar lavage fluid (BALF) was examined using enzyme-linked immunosorbent assay. We measured VEGF, HIF-1alpha, and HIF-2alpha expression on biopsy specimens by means of immunoreactivity. RESULTS: The VEGF level in the BALF was significantly higher in asthmatic patients than in controls. The VEGF level correlated with eosinophil counts in the BALF in asthmatic subjects (r = 0.501; P < .01). However, the VEGF level did not correlate with percentage of forced expiratory volume in 1 second and airway hyperresponsiveness. Asthmatic patients exhibited higher VEGF, HIF-1alpha, and HIF-2alpha immunoreactivity in the submucosa than did controls. Furthermore, VEGF expression correlated significantly with HIF-1alpha (r = 0.614; P = .02) and HIF-2alpha (r = 0.881; P = .001) expression. CONCLUSION: These findings suggest that VEGF may play an important role in inflammation and that VEGF level is related to HIF in bronchial asthma.
Authors: S Huerta-Yepez; G J Baay-Guzman; I G Bebenek; R Hernandez-Pando; M I Vega; L Chi; M Riedl; D Diaz-Sanchez; E Kleerup; D P Tashkin; F J Gonzalez; B Bonavida; M Zeidler; Oliver Hankinson Journal: Allergy Date: 2011-04-26 Impact factor: 13.146
Authors: Nels Olson; Milena Hristova; Nicholas H Heintz; Karen M Lounsbury; Albert van der Vliet Journal: Am J Physiol Lung Cell Mol Physiol Date: 2011-09-16 Impact factor: 5.464
Authors: Nels Olson; David I Kasahara; Milena Hristova; Risa Bernstein; Yvonne Janssen-Heininger; Albert van der Vliet Journal: Am J Respir Cell Mol Biol Date: 2010-08-06 Impact factor: 6.914
Authors: Seoung Ju Park; Kyung Sun Lee; So Ri Kim; Han Jung Chae; Wan Hee Yoo; Dong Im Kim; Myoung Shin Jeon; Yong Chul Lee Journal: Inflamm Res Date: 2012-06-13 Impact factor: 4.575
Authors: Laura E Crotty Alexander; Kathryn Akong-Moore; Stephanie Feldstein; Per Johansson; Anh Nguyen; Elisa K McEachern; Shari Nicatia; Andrew S Cowburn; Joshua Olson; Jae Youn Cho; Hart Isaacs; Randall S Johnson; David H Broide; Victor Nizet Journal: J Mol Med (Berl) Date: 2012-12-19 Impact factor: 4.599